Savior LLC Eli Lilly & CO Transaction History

Savior LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$224.85 - $279.04 $7,869 - $9,766	-35 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$221.6 - $272.71 $26,148 - $32,179	-118 Reduced 77.12%	35 $8,000
Q2 2021 Jul 09, 2021	SELL	$180.55 - $233.54 $21,124 - $27,324	-117 Reduced 43.33%	153 $35,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $39,007 - $51,616	-299 Reduced 52.55%	270 $46,000
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $292 - $338	2 Added 0.35%	569 $84,000
Q2 2020 Jul 28, 2020	BUY	$136.42 - $164.18 $4,911 - $5,910	36 Added 6.78%	567 $93,000
Q1 2020 Apr 22, 2020	SELL	$119.05 - $147.35 $952 - $1,178	-8 Reduced 1.48%	531 $74,000
Q4 2019 Jan 22, 2020	BUY	$106.92 - $132.43 $57,629 - $71,379	539 New	539 $71,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

Stay updated on Savior LLC with notifications on news.